Patents by Inventor Tamara REYES-ROBLES

Tamara REYES-ROBLES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets
    Patent number: 11932683
    Abstract: The present invention relates to methods for treating and preventing Staphylococcus aureus infection and/or a condition resulting from a S. aureus infection in a subject that involves administering compositions that inhibit S. aureus interaction with CXCR1/CXCR2 and DARC cellular receptors. The present invention further relates to novel compositions for carrying out these and other methods.
    Type: Grant
    Filed: September 14, 2022
    Date of Patent: March 19, 2024
    Assignee: NEW YORK UNIVERSITY
    Inventors: Victor J. Torres, Tamara Reyes-Robles, Francis Alonzo
  • CELLULAR FACTORS INVOLVED IN THE CYTOTOXICITY OF STAPHYLOCOCCUS AUREUS LEUKOCIDINS: NOVEL THERAPEUTIC TARGETS
    Publication number: 20230151081
    Abstract: The present invention relates to methods for treating and preventing Staphylococcus aureus infection and/or a condition resulting from a S. aureus infection in a subject that involves administering compositions that inhibit S. aureus interaction with CXCR1/CXCR2 and DARC cellular receptors. The present invention further relates to novel compositions for carrying out these and other methods.
    Type: Application
    Filed: September 14, 2022
    Publication date: May 18, 2023
    Inventors: Victor J. TORRES, Tamara REYES-ROBLES, Francis ALONZO
  • PROXIMITY-BASED LABELING SYSTEMS AND APPLICATIONS THEREOF
    Publication number: 20220306683
    Abstract: In one aspect, compositions and methods are described herein for providing a microenvironment mapping platform operable to selectively identify various features, including protein-protein interactions on cellular membranes. In some embodiments, a composition comprises a catalyst, and a protein labeling agent, wherein the catalyst activates the protein labeling agent to a reactive intermediate. The catalyst, in some embodiments, can have electronic structure for permitting energy transfer to the protein labeling agent to form the reactive intermediate. The reactive intermediate reacts or crosslinks with a protein or other biomolecule within the diffusion radius of the reactive intermediate.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 29, 2022
    Inventors: David W.C. MACMILLAN, Jacob GERI, Tao WANG, James OAKLEY, Tamara REYES-ROBLES, Rob C. OSLUND, Olugbeminiyi O. FADEYI, Dann LeRoy Parker, Frances Paola RODRIGUEZ-RIVERA, Stefan MCCARVER
  • Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets
    Patent number: 11453715
    Abstract: The present invention relates to methods for treating and preventing Staphylococcus aureus infection and/or a condition resulting from a S. aureus infection in a subject that involves administering compositions that inhibit S. aureus interaction with CXCR1/CXCR2 and DARC cellular receptors. The present invention further relates to novel compositions for carrying out these and other methods.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: September 27, 2022
    Assignee: NEW YORK UNIVERSITY
    Inventors: Victor J. Torres, Tamara Reyes-Robles, Francis Alonzo, III
  • CELLULAR FACTORS INVOLVED IN THE CYTOTOXICITY OF STAPHYLOCOCCUS AUREUS LEUKOCIDINS: NOVEL THERAPEUTIC TARGETS
    Publication number: 20210009664
    Abstract: The present invention relates to methods for treating and preventing Staphylococcus aureus infection and/or a condition resulting from a S. aureus infection in a subject that involves administering compositions that inhibit S. aureus interaction with CXCR1/CXCR2 and DARC cellular receptors. The present invention further relates to novel compositions for carrying out these and other methods.
    Type: Application
    Filed: June 5, 2020
    Publication date: January 14, 2021
    Inventors: Victor J. TORRES, Tamara REYES-ROBLES, Francis ALONZO, III
  • CELLULAR FACTORS INVOLVED IN THE CYTOTOXICITY OF STAPHYLOCOCCUS AUREUS LEUKOCIDINS: NOVEL THERAPEUTIC TARGETS
    Publication number: 20190248876
    Abstract: The present invention relates to methods for treating and preventing Staphylococcus aureus infection and/or a condition resulting from a S. aureus infection in a subject that involves administering compositions that inhibit S. aureus interaction with CXCR1/CXCR2 and DARC cellular receptors. The present invention further relates to novel compositions for carrying out these and other methods.
    Type: Application
    Filed: April 24, 2019
    Publication date: August 15, 2019
    Inventors: Victor J. TORRES, Tamara REYES-ROBLES, Francis ALONZO, III
  • Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets
    Patent number: 10301378
    Abstract: The present invention relates to methods for treating and preventing Staphylococcus aureus infection and/or a condition resulting from a S. aureus infection in a subject that involves administering compositions that inhibit S. aureus interaction with CXCR1/CXCR2 and DARC cellular receptors. The present invention further relates to novel compositions for carrying out these and other methods.
    Type: Grant
    Filed: June 18, 2014
    Date of Patent: May 28, 2019
    Assignee: New York University
    Inventors: Victor J. Torres, Tamara Reyes-Robles, Francis Alonzo, III
  • CELLULAR FACTORS INVOLVED IN THE CYTOTOXICITY OF STAPHYLOCOCCUS AUREUS LEUKOCIDINS: NOVEL THERAPEUTIC TARGETS
    Publication number: 20160168233
    Abstract: The present invention relates to methods for treating and preventing Staphylococcus aureus infection and/or a condition resulting from a S. aureus infection in a subject that involves administering compositions that inhibit S. aureus interaction with CXCR1/CXCR2 and DARC cellular receptors. The present invention further relates to novel compositions for carrying out these and other methods.
    Type: Application
    Filed: June 18, 2014
    Publication date: June 16, 2016
    Inventors: Victor J. TORRES, Tamara REYES-ROBLES, Francis ALONZO, III